# Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1

> **NCT03879655** · PHASE2,PHASE3 · TERMINATED · sponsor: **Mandos LLC** · enrollment: 2 (actual)

## Conditions studied

- Niemann-Pick Disease, Type C

## Interventions

- **DRUG:** VTS-270

## Key facts

- **NCT ID:** NCT03879655
- **Lead sponsor:** Mandos LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-02
- **Primary completion:** 2021-10-18
- **Final completion:** 2021-10-18
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Terminated by previous Sponsor decision
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03879655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03879655, "Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03879655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*